TCL Archive EPO Controversy: ODAC To Review EPO Agents in May; SEC Probes Amgen’s Delay in Study Disclosure. March 2, 2007
TCL Archive Breast Cancer Funding: Shalala Approves Agreement Over Disputed $14 Million August 8, 1997